Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 15;122(12):1921-7.
doi: 10.1002/cncr.30000. Epub 2016 Apr 8.

Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data

Priscila H Goncalves  1 , Stephanie L Peterson  2 , Fawn D Vigneau  1 , Ronald D Shore  1 , William O Quarshie  3 , Khairul Islam  4 , Ann G Schwartz  1 , Antoinette J Wozniak  1 , Shirish M Gadgeel  1
Affiliations

Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data

Priscila H Goncalves et al. Cancer. .

Abstract

Background: Brain metastases (BM) remain an important cause of morbidity and mortality in patients with lung cancer. The current study evaluated population-based incidence and outcomes of BM in patients with nonmetastatic lung cancer.

Methods: Patients diagnosed with nonmetastatic first primary lung cancer between 1973 and 2011 in the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) registry were used for the current analysis. Age-adjusted odds ratios of developing BM based on various demographic characteristics and histology were calculated with 95% confidence intervals. Adjusted Cox proportional hazard ratios and log-rank tests of Kaplan-Meier survival curves were calculated to evaluate survival differences for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Results: The incidence of BM in patients with nonmetastatic NSCLC and SCLC was 9% and 18%, respectively. There was variation in the incidence of BM according to NCSLC histology. The incidence of BM was higher in patients aged <60 years for both NSCLC and SCLC, but there were no differences noted by race for either histological group. Female patients with NSCLC were more likely to have BM than male patients. There was variation in the proportion of BM in both patients with NSCLC and SCLC over the three 13-year periods of diagnosis. The risk of death (hazard ratio) was found to be significantly higher for patients with NSCLC with BM, but was not significantly higher in patients with SCLC with BM.

Conclusions: The incidence of BM in patients with nonmetastatic lung cancer varies according to histology, age, and sex. BM are associated with worse survival for patients with NSCLC but not those with SCLC. Cancer 2016;122:1921-7. © 2016 American Cancer Society.

Keywords: Surveillance, Epidemiology, and End Results (SEER); brain metastases; brain metastasis; lung cancer; nonmetastatic lung cancer.

PubMed Disclaimer

Conflict of interest statement

The following authors have no financial disclosures or conflicts of interest to report: PG, SP, FV, RS, WQ, KI, AW and SG. AS received NIH grant support.

Figures

Figure 1
Figure 1
legend - Survival of invasive first sequence non-small cell lung cancer by brain metastases, Metropolitan Detroit SEER, 1973–2011. Abbreviations: mets – metastases, SEER – Surveillance, Epidemiology and End Results
Figure 2
Figure 2
legend - Survival of invasive first sequence small cell lung cancer by brain metastases, Metropolitan Detroit SEER, 1973–2011. Abbreviations: mets – metastases, SEER – Surveillance, Epidemiology and End Results
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kehrli P. Epidemiology of brain metastases. Neurochirurgie. 1999;45:357–363. - PubMed
    1. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14:48–54. - PubMed
    1. Percy AK, Elveback LR, Okazaki H, Kurland LT. Neoplasms of the central nervous system. Epidemiologic considerations. Neurology. 1972;22:40–48. - PubMed
    1. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology. 1985;35:219–226. - PubMed
    1. Counsell CE, Collie DA, Grant R. Incidence of intracranial tumours in the Lothian region of Scotland, 1989–90. J Neurol Neurosurgery Psychiatry. 1996;61:143–150. - PMC - PubMed

Publication types